You are here

  • Home
  • Archive
  • Volume 73, Issue 2
  • Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy

Article metrics

Article menu
Download PDFPDF
Short report
Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy

 

Online download statistics by month:

Online download statistics by month: September 2019 to March 2025

AbstractFullPdf
Sep 20197563719
Oct 2019265189
Nov 20199773
Dec 201910692
Jan 20203013520
Feb 20203332113
Mar 202018984
Apr 202011585
May 20208841
Jun 202011585
Jul 202013452
Aug 20206274
Sep 202012073
Oct 20204784
Nov 20206153
Dec 20206743
Jan 20216274
Feb 20219464
Mar 20219452
Apr 20216231
May 20211824
Jun 2021422
Jul 2021110
Aug 2021530
Sep 2021531
Oct 20214450
Nov 20215433
Dec 202120634
Jan 20224310
Feb 20227642
Mar 20226873
Apr 20224020
May 20227830
Jun 20226630
Jul 202267100
Aug 20227320
Sep 20226120
Oct 202211330
Nov 20221710
Dec 20223211
Jan 20233511
Feb 20235910
Mar 20232731
Apr 20232110
May 20232531
Jun 20236830
Jul 20232100
Aug 20231721
Sep 20231310
Oct 20231520
Nov 20231710
Dec 20233210
Jan 2024800
Feb 20241600
Mar 20242200
Apr 20243400
May 20241510
Jun 20243621
Jul 20243311
Aug 20242400
Sep 202411910
Oct 20242722
Nov 20245000
Dec 20246221
Jan 20251911
Feb 2025521
Mar 2025200
Total5061304142